Daisuke Uchida
Impact in
- Oncology top 2%
- Chemokine receptors and signaling
- HER2/EGFR in Cancer Research
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 2%
- NF-κB Signaling Pathways
Papers in
-
- TGF-β signaling in diseases 8
- Oncology 34
- Chemokine receptors and signaling 11
- Cancer Diagnosis and Treatment 6
- Cancer-related Molecular Pathways 6
- Co-authors
- Hitoshi Kawamata (37 shared papers)Toshi Komurasaki (4 shared papers)Hitoshi Toyoda (4 shared papers)Koh‐ichi Nakashiro (30 shared papers)Hideo Yoshida (7 shared papers)Yoshifumi Tomizuka (6 shared papers)Mitsunobu Sato (9 shared papers)Fumie Omotehara (17 shared papers)
- Journals
- International Journal of Oncology (8 papers)Oncology Reports (5 papers)British Journal of Cancer (5 papers)Cancer Research (4 papers)International Journal of Oral and Maxillofacial Surgery (3 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Daisuke Uchida
80 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 104
- Oncology 1.1k
- Cancer Research 614
- Immunology 690
- Otorhinolaryngology 110
- Hepatology 176
Countries citing papers authored by Daisuke Uchida
This map shows the geographic impact of Daisuke Uchida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Uchida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Uchida more than expected).
Fields of papers citing papers by Daisuke Uchida
This network shows the impact of papers produced by Daisuke Uchida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Uchida. The network helps show where Daisuke Uchida may publish in the future.
Co-authors
The 25 scholars most cited alongside Daisuke Uchida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 248 | |
| 2 | 2001 | 178 | |
| 3 | 2003 | 152 | |
| 4 | 2000 | 147 | |
| 5 | 1997 | 125 | |
| 6 | 2006 | 124 | |
| 7 | 2004 | 119 | |
| 8 | 1997 | 119 | |
| 9 | 1997 | 117 | |
| 10 | 2013 | 113 | |
| 11 | 2015 | 98 | |
| 12 | 2004 | 86 | |
| 13 | 2001 | 80 | |
| 14 | 2004 | 73 | |
| 15 | 2007 | 69 | |
| 16 | 1998 | 67 | |
| 17 | Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. | 1998 | 66 |
| 18 | 2004 | 60 | |
| 19 | 2010 | 55 | |
| 20 | 1998 | 46 |
About Daisuke Uchida
Daisuke Uchida is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Otorhinolaryngology, having authored 85 papers that have together received 2.8k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (12 papers), Chemokine receptors and signaling (11 papers), Cancer-related molecular mechanisms research (9 papers), TGF-β signaling in diseases (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Cancer Diagnosis and Treatment (6 papers), Immunotherapy and Immune Responses (6 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (614 citations), Immunology (690 citations), Otorhinolaryngology (110 citations) and Hepatology (176 citations). Daisuke Uchida has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Hitoshi Kawamata, Toshi Komurasaki, Hitoshi Toyoda, Koh‐ichi Nakashiro, Hideo Yoshida, Yoshifumi Tomizuka, Mitsunobu Sato, Fumie Omotehara, Mitsuru Matsumoto and Akemi Matsushima. Their work appears in journals such as International Journal of Oncology, Oncology Reports, British Journal of Cancer, Cancer Research and International Journal of Oral and Maxillofacial Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.